COYA
COYA
NASDAQ · Biotechnology

Coya Therapeutics Inc

$4.84
+0.42 (+9.50%)
As of Feb 8, 2:11 PM ET ·
Income Statement
FY 2025 FY 2024 FY 2023
Revenue 21.48M 20.04M 21.53M
Net Income -5,165,355 -3,853,498 -4,413,133
EPS
Profit Margin -24.1% -19.2% -20.5%
Rev Growth -8.7% +0.8% +4.3%
Balance Sheet
FY 2025 FY 2024 FY 2023
Total Debt 20.03M 19.96M 21.21M
Total Equity 82.70M 80.09M 74.44M
D/E Ratio 0.24 0.25 0.29
Cash Flow
FY 2025 FY 2024 FY 2023
EBITDA -6,655,427 -5,995,002 -5,792,790
Free Cash Flow -3,535,951 -2,421,928 -4,008,931